{{Drugbox
| Verifiedfields = changed
| Watchedfields = changed
| verifiedrevid = 460783591
| IUPAC_name = 4,5-Dichlorobenzene-1,3-disulfonamide
| image = Diclofenamide.svg
| alt = Skeletal formula of diclofenamide
| image2 = Diclofenamide-3D-spacefill.png
| alt2 = Space-filling model of diclofenamide
<!--Clinical data-->
| tradename =  
| Drugs.com = {{drugs.com|international|diclofenamide}}
| MedlinePlus = a601233
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X -->
| pregnancy_US = <!-- A / B / C / D / X -->
| pregnancy_category =  
| legal_AU = <!-- Unscheduled / S2 / S4 / S8 -->
| legal_UK = <!-- GSL / P / POM / CD -->
| legal_US = <!-- OTC / Rx-only -->
| legal_status =  
| routes_of_administration =  
<!--Pharmacokinetic data-->
| bioavailability =  
| protein_bound = 55%
| metabolism =  
| elimination_half-life =  
| excretion =  
<!--Identifiers-->
| IUPHAR_ligand = 6807
| CAS_number_Ref = {{cascite|correct|??}}
| CAS_number = 120-97-8
| ATC_prefix = S01
| ATC_suffix = EC02
| ATC_supplemental =  
| PubChem = 3038
| DrugBank_Ref = {{drugbankcite|changed|drugbank}}
| DrugBank = DB01144
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID = 2930
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = VVJ6673MHY
| KEGG_Ref = {{keggcite|correct|kegg}}
| KEGG = D00518
| ChEBI_Ref = {{ebicite|correct|EBI}}
| ChEBI = 101085
| ChEMBL_Ref = {{ebicite|correct|EBI}}
| ChEMBL = 17
<!--Chemical data-->
| C=6 | H=6 | Cl=2 | N=2 | O=4 | S=2
| molecular_weight = 305.16 g/mol
| smiles = Clc1c(cc(cc1Cl)S(=O)(=O)N)S(=O)(=O)N
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI = 1S/C6H6Cl2N2O4S2/c7-4-1-3(15(9,11)12)2-5(6(4)8)16(10,13)14/h1-2H,(H2,9,11,12)(H2,10,13,14)
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| StdInChIKey = GJQPMPFPNINLKP-UHFFFAOYSA-N
| melting_point = 228.5
}}

'''Diclofenamide''' (or '''dichlorphenamide''') is a [[sulfonamide (medicine)|sulfonamide]] and a [[carbonic anhydrase inhibitor]] of the ''meta''-disulfamoylbenzene class.

==Uses==
Diclofenamide is used to treat [[glaucoma]]<ref>{{drugs.com|international|diclofenamide.html}}: Diclofenamide</ref><ref>{{Cite journal | doi = 10.1136/bjo.52.8.642 | last1 = Kanski | first1 = J. J. | title = Carbonic anhydrase inhibitors and osmotic agents in glaucoma. Carbonic anhydrase inhibitors | journal = The British journal of ophthalmology | volume = 52 | issue = 8 | pages = 642–643 | year = 1968 | pmid = 5724852 | pmc = 506660}}</ref> and therapy-resistant [[epilepsy]].<ref>{{Cite journal | last1 = Rucquoy | first1 = M. | last2 = Sorel | first2 = L. | title = Diclofenamide in the treatment of therapy-resistant epilepsy | journal = Acta Neurologica Belgica | volume = 78 | issue = 3 | pages = 174–182 | year = 1978 | pmid = 352085}}</ref>

==References==
{{Reflist}}

{{Antiglaucoma preparations and miotics}}

[[Category:Carbonic anhydrase inhibitors]]
[[Category:Sulfonamides]]
[[Category:Chloroarenes]]


{{antihypertensive-stub}}